William Frazier - 29 Jan 2024 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol
VMD
Transactions as of
29 Jan 2024
Net transactions value
-$12,180
Form type
4
Filing time
31 Jan 2025, 15:27:23 UTC
Previous filing
28 Aug 2023
Next filing
26 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +2,335 +3.4% 70,143 29 Jan 2025 Direct F1
transaction VMD Common Shares Tax liability $5,738 -693 -0.99% $8.28 69,450 29 Jan 2025 Direct F2, F3
transaction VMD Common Shares Options Exercise +778 +1.1% 70,228 29 Jan 2025 Direct F4
transaction VMD Common Shares Disposed to Issuer $6,442 -778 -1.1% $8.28 69,450 29 Jan 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Restricted Stock Units Award $0 +7,003 $0.000000 7,003 29 Jan 2024 Common Shares 7,003 Direct F1, F5, F6
transaction VMD Phantom Share Units Award $0 +2,334 $0.000000 2,334 29 Jan 2024 Common Shares 2,334 Direct F5, F7, F8
transaction VMD Restricted Stock Units Award $0 +10,201 $0.000000 10,201 21 Jan 2025 Common Shares 10,201 Direct F1, F5, F9
transaction VMD Phantom Share Units Award $0 +2,550 $0.000000 2,550 21 Jan 2025 Common Shares 2,550 Direct F5, F7, F10
transaction VMD Restricted Stock Units Options Exercise $0 -2,335 -33% $0.000000 4,668 29 Jan 2025 Common Shares 2,335 Direct F1, F6
transaction VMD Phantom Share Units Options Exercise $0 -778 -33% $0.000000 1,556 29 Jan 2025 Common Shares 778 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2 Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F3 Per share value is based on the market closing price of the common shares for January 29, 2025.
F4 Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F5 This transaction is being reported late due to an administrative error in processing the grant details; the reporting person took immediate steps to rectify the issue upon discovery.
F6 Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F7 Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
F8 Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F9 Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F10 Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.